These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28893228)

  • 1. XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis.
    Hussain AR; Siraj AK; Ahmed M; Bu R; Pratheeshkumar P; Alrashed AM; Qadri Z; Ajarim D; Al-Dayel F; Beg S; Al-Kuraya KS
    BMC Cancer; 2017 Sep; 17(1):640. PubMed ID: 28893228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of X-Linked Inhibitor of Apoptosis as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
    Hussain AR; Bu R; Ahmed M; Jehan Z; Beg S; Al-Sobhi S; Al-Dayel F; Siraj AK; Uddin S; Al-Kuraya KS
    J Clin Endocrinol Metab; 2015 Jul; 100(7):E974-85. PubMed ID: 25974735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.
    Prabhu KS; Siveen KS; Kuttikrishnan S; Iskandarani A; Tsakou M; Achkar IW; Therachiyil L; Krishnankutty R; Parray A; Kulinski M; Merhi M; Dermime S; Mohammad RM; Uddin S
    PLoS One; 2017; 12(7):e0180895. PubMed ID: 28704451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling.
    Hussain AR; Uddin S; Ahmed M; Bu R; Ahmed SO; Abubaker J; Sultana M; Ajarim D; Al-Dayel F; Bavi PP; Al-Kuraya KS
    J Pathol; 2010 Oct; 222(2):180-90. PubMed ID: 20632385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment.
    Siraj AK; Pratheeshkumar P; Parvathareddy SK; Divya SP; Al-Dayel F; Tulbah A; Ajarim D; Al-Kuraya KS
    Oncotarget; 2018 Dec; 9(99):37319-37332. PubMed ID: 30647872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.
    Strekalova E; Malin D; Rajanala H; Cryns VL
    Breast Cancer Res Treat; 2017 Jun; 163(3):435-447. PubMed ID: 28324269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer.
    Rajput S; Kumar BN; Sarkar S; Das S; Azab B; Santhekadur PK; Das SK; Emdad L; Sarkar D; Fisher PB; Mandal M
    PLoS One; 2013; 8(4):e61342. PubMed ID: 23613836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.
    Xie X; Tang B; Zhou J; Gao Q; Zhang P
    Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
    Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells.
    Qian H; Huang T; Chen Y; Li X; Gong W; Jiang G; Zhang W; Cheng S; Li X; Li P
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S648-S655. PubMed ID: 30249882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HDAC inhibitor OBP-801 and a PI3K inhibitor LY294002 synergistically induce apoptosis via the suppression of survivin and XIAP in renal cell carcinoma.
    Yamada T; Horinaka M; Shinnoh M; Yoshioka T; Miki T; Sakai T
    Int J Oncol; 2013 Oct; 43(4):1080-6. PubMed ID: 23900601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
    Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
    J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro.
    Fu X; Pang X; Qi H; Chen S; Li Y; Tan W
    Clin Transl Oncol; 2016 Mar; 18(3):277-82. PubMed ID: 26209051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between NF-kappa B inhibitor, celastrol, and XIAP inhibitor, embelin, in an acute myeloid leukemia cell line, HL-60.
    Pazhang Y; Jaliani HZ; Imani M; Dariushnejad H
    J Cancer Res Ther; 2016; 12(1):155-60. PubMed ID: 27072230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation.
    Yang T; Lan J; Huang Q; Chen X; Sun X; Liu X; Yang P; Jin T; Wang S; Mou X
    Cell Biochem Biophys; 2015 Jan; 71(1):291-7. PubMed ID: 25358405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells.
    Allensworth JL; Aird KM; Aldrich AJ; Batinic-Haberle I; Devi GR
    Mol Cancer Ther; 2012 Jul; 11(7):1518-27. PubMed ID: 22508521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy.
    Ren M; Wang Z; Gao G; Gu X; Wu L; Chen L
    Tumour Biol; 2016 Sep; 37(9):11825-11833. PubMed ID: 27048285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression.
    Aird KM; Ding X; Baras A; Wei J; Morse MA; Clay T; Lyerly HK; Devi GR
    Mol Cancer Ther; 2008 Jan; 7(1):38-47. PubMed ID: 18202008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells.
    Wang DG; Sun YB; Ye F; Li W; Kharbuja P; Gao L; Zhang DY; Suo J
    Mol Cell Biochem; 2014 Jan; 386(1-2):143-52. PubMed ID: 24136460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.
    Aird KM; Ghanayem RB; Peplinski S; Lyerly HK; Devi GR
    Mol Cancer Ther; 2010 May; 9(5):1432-42. PubMed ID: 20406946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.